Surgery Partners CS (SGRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 864,400 | 770,400 | 762,100 | 717,400 | 735,400 |
| Cost of Goods | 630,800 | 592,900 | 582,900 | 562,100 | 541,800 |
| Gross Profit | 233,600 | 177,500 | 179,200 | 155,300 | 193,600 |
| Operating Expenses | 107,300 | 117,500 | 95,300 | 79,400 | 93,000 |
| Operating Income | 127,100 | 60,900 | 84,800 | 76,000 | 101,400 |
| Interest Expense | 60,100 | 55,200 | 55,900 | 50,000 | 53,500 |
| Other Income | 7,200 | 5,200 | 4,400 | 2,700 | 4,800 |
| Pre-tax Income | 74,200 | 10,900 | 33,300 | 28,700 | 52,700 |
| Income Tax | 120,800 | 4,500 | 4,900 | 4,400 | 6,000 |
| Net Income Continuous | -46,600 | 6,400 | 28,400 | 24,300 | 46,700 |
| Minority Interests | 61,900 | 38,100 | 43,900 | 36,700 | 47,700 |
| Net Income | $-108,500 | $-31,700 | $-15,500 | $-12,400 | $-1,000 |
| EPS Basic Total Ops | -0.86 | -0.25 | -0.12 | -0.10 | 0.00 |
| EPS Basic Continuous Ops | -0.37 | 0.05 | 0.23 | 0.19 | 0.37 |
| EPS Diluted Total Ops | -0.86 | -0.25 | -0.12 | -0.10 | 0.00 |
| EPS Diluted Continuous Ops | -0.37 | 0.05 | 0.23 | 0.19 | 0.38 |
| EPS Diluted Before Non-Recurring Items | 0.39 | 0.13 | 0.10 | N/A | N/A |
| EBITDA(a) | $168,200 | $116,300 | $124,000 | $112,400 | $137,300 |